PAVmed Inc. (PAVM)

Regulus Therapeutics Revenue

PAVmed had revenue of $8.00K in the quarter ending March 31, 2025, a decrease of -99.21%. This brings the company's revenue in the last twelve months to $1.99M, down -33.92% year-over-year. In the year 2024, PAVmed had annual revenue of $3.00M with 22.15% growth.

• Revenue (ttm): $1.99M
• Revenue Growth: -33.92%
• P/S Ratio: 2.55
• Revenue / Employee: $51,103
• Employees: 39
• Market Cap: 8.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.00M	543.00K	22.15%
Dec 31, 2023	2.45M	2.08M	550.40%
Dec 31, 2022	377.00K	-123.00K	-24.60%
Dec 31, 2021	500.00K	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.